Lack of association of very low density lipoprotein receptor gene polymorphism with Caucasian Alzheimer's disease. 1996

K Okuizumi, and O Onodera, and K Seki, and H Tanaka, and Y Namba, and K Ikeda, and A M Saunders, and M A Pericak-Vance, and A D Roses, and S Tsuji
Department of Neurology, Brain Research Institute, Niigata University, Japan.

To determine whether the association of the very low density lipoprotein receptor (VLDL-R) gene with Alzheimer's disease (AD), which has recently been identified in Japanese AD patients, is commonly observed in AD patients of other ethnic backgrounds, we have investigated the allele frequency of the polymorphic CGG repeat in the 5'-UTR of the VLDL-R gene using a data set of 84 Caucasian AD patients with 104 Caucasian controls. Although the allele frequency of the 8-repeat allele was slightly lower, and that of 9-repeat allele was slightly higher, in the Caucasian AD patients than in Caucasian controls, the differences were not statistically significant. Multiple logistic regression analysis using apolipoprotein E4 (APOE4) allele, 5, 8-, or 9-repeat allele of the VLDL-R gene, sex, and age at onset as the predictors revealed that only the APOE4 allele was significantly associated with AD in the data set of the Caucasian AD patients and controls.

UI MeSH Term Description Entries
D007564 Japan A country in eastern Asia, island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. The capital is Tokyo. Bonin Islands
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000483 Alleles Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product. Allelomorphs,Allele,Allelomorph
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia
D001057 Apolipoproteins E A class of protein components which can be found in several lipoproteins including HIGH-DENSITY LIPOPROTEINS; VERY-LOW-DENSITY LIPOPROTEINS; and CHYLOMICRONS. Synthesized in most organs, Apo E is important in the global transport of lipids and cholesterol throughout the body. Apo E is also a ligand for LDL receptors (RECEPTORS, LDL) that mediates the binding, internalization, and catabolism of lipoprotein particles in cells. There are several allelic isoforms (such as E2, E3, and E4). Deficiency or defects in Apo E are causes of HYPERLIPOPROTEINEMIA TYPE III. Apo-E,Apo E,Apo E Isoproteins,ApoE,Apolipoprotein E Isoproteins,Apoprotein (E),Apoproteins E,Isoproteins, Apo E,Isoproteins, Apolipoprotein E
D014481 United States A country in NORTH AMERICA between CANADA and MEXICO.
D015243 Cholesterol, VLDL Cholesterol which is contained in or bound to very low density lipoproteins (VLDL). High circulating levels of VLDL cholesterol are found in HYPERLIPOPROTEINEMIA TYPE IIB. The cholesterol on the VLDL is eventually delivered by LOW-DENSITY LIPOPROTEINS to the tissues after the catabolism of VLDL to INTERMEDIATE-DENSITY LIPOPROTEINS, then to LDL. VLDL Cholesterol,Pre-beta-Lipoprotein Cholesterol,Prebetalipoprotein Cholesterol,Very Low Density Lipoprotein Cholesterol,Cholesterol, Pre-beta-Lipoprotein,Cholesterol, Prebetalipoprotein,Pre beta Lipoprotein Cholesterol
D044465 White People Persons having origins in any of the white racial groups of Europe, the Middle East, or North Africa. Note that OMB category WHITE is available for the United States population groups. Race and ethnicity terms, as used in the federal government, are self-identified social construct and may include terms outdated and offensive in MeSH to assist users who are interested in retrieving comprehensive search results for studies such as in longitudinal studies. European Continental Ancestry Group,White Person,Caucasian Race,Caucasoid Race,Caucasian Races,Caucasoid Races,People, White,Person, White,Race, Caucasian,Race, Caucasoid,White Peoples,White Persons

Related Publications

K Okuizumi, and O Onodera, and K Seki, and H Tanaka, and Y Namba, and K Ikeda, and A M Saunders, and M A Pericak-Vance, and A D Roses, and S Tsuji
June 1996, Annals of neurology,
K Okuizumi, and O Onodera, and K Seki, and H Tanaka, and Y Namba, and K Ikeda, and A M Saunders, and M A Pericak-Vance, and A D Roses, and S Tsuji
May 1998, Neuroscience letters,
K Okuizumi, and O Onodera, and K Seki, and H Tanaka, and Y Namba, and K Ikeda, and A M Saunders, and M A Pericak-Vance, and A D Roses, and S Tsuji
August 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics,
K Okuizumi, and O Onodera, and K Seki, and H Tanaka, and Y Namba, and K Ikeda, and A M Saunders, and M A Pericak-Vance, and A D Roses, and S Tsuji
October 1997, Archives of neurology,
K Okuizumi, and O Onodera, and K Seki, and H Tanaka, and Y Namba, and K Ikeda, and A M Saunders, and M A Pericak-Vance, and A D Roses, and S Tsuji
January 2005, Neurobiology of aging,
K Okuizumi, and O Onodera, and K Seki, and H Tanaka, and Y Namba, and K Ikeda, and A M Saunders, and M A Pericak-Vance, and A D Roses, and S Tsuji
August 2008, Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics,
K Okuizumi, and O Onodera, and K Seki, and H Tanaka, and Y Namba, and K Ikeda, and A M Saunders, and M A Pericak-Vance, and A D Roses, and S Tsuji
August 2000, Microscopy research and technique,
K Okuizumi, and O Onodera, and K Seki, and H Tanaka, and Y Namba, and K Ikeda, and A M Saunders, and M A Pericak-Vance, and A D Roses, and S Tsuji
November 1996, Neurology,
K Okuizumi, and O Onodera, and K Seki, and H Tanaka, and Y Namba, and K Ikeda, and A M Saunders, and M A Pericak-Vance, and A D Roses, and S Tsuji
May 2006, Journal of gastroenterology and hepatology,
K Okuizumi, and O Onodera, and K Seki, and H Tanaka, and Y Namba, and K Ikeda, and A M Saunders, and M A Pericak-Vance, and A D Roses, and S Tsuji
July 1993, Seikagaku. The Journal of Japanese Biochemical Society,
Copied contents to your clipboard!